Reciprocal regulation of adipocyte and osteoblast differentiation of mesenchymal stem cells by eupatorium japonicum prevents bone loss and adiposity increase in osteoporotic rats

Journal of Medicinal Food

Volumn 17, Issue 7, 2014, Pages 772-781

  Kim, Min Ji ^a   Jang, Woo Seok ^a   Lee, In Kyoung ^b   Kim, Jong Keun ^a,c   Seong, Ki Seung ^d   Seo, Cho Rong ^a   Song, No Joon ^a   Bang, Min Hyuk ^a   Lee, Young Min ^e   Kim, Haeng Ran ^e   Park, Ki Moon ^a   Park, Kye Won ^a  

^a Sungkyunkwan University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Sungkyun Biotech Co Ltd   (South Korea)

^d Korea Food Research Institute   (South Korea)

^e National Institute of Animal Science   (South Korea)

Author keywords

bone marrow; C3H10T1 2; coumaric acid; Eupatorium japonicum; osteoporosis; ovariectomized rat

Indexed keywords

ALKALINE PHOSPHATASE; COUMARIC ACID; EUPATORIUM JAPONICUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; 4-COUMARIC ACID METHYL ESTER;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MARROW CELL; CELL DIFFERENTIATION; EUPATORIUM; EUPATORIUM JAPONICUM; LIPID STORAGE; NONHUMAN; OBESITY; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PLANT STEM; PRIORITY JOURNAL; RAT; 3T3 CELL LINE; ADIPOGENESIS; ANIMAL; BONE DISEASES, METABOLIC; CHEMISTRY; COMPLICATION; CYTOLOGY; DRUG EFFECTS; FEMALE; LIPID METABOLISM; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT;

3T3 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOSITY; ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE MARROW CELLS; CELL DIFFERENTIATION; COUMARIC ACIDS; EUPATORIUM; FEMALE; LIPID METABOLISM; MESENCHYMAL STROMAL CELLS; MICE; OSTEOBLASTS; OSTEOPOROSIS; PLANT EXTRACTS; PLANT STEMS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84904293120     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.3056     Document Type: Article

References (33)

1. Henry MJ, Pasco JA, Seeman E, et al.: Assessment of fracture risk: value of random population-based samples-the Geelong Osteoporosis Study. J Clin Densitom 2001;4:283-289. (Pubitemid 34073197)
2. Montagnani A, Gonnelli S, Alessandri M, Nuti R: Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res 2011;23:84-90.
3. Silva BC, Bilezikian JP: New approaches to the treatment of osteoporosis. Annu Rev Med 2010;62:307-322.
4. Turgeon JL, McDonnell DP, Martin KA, Wise PM: Hormone therapy: physiological complexity belies therapeutic simplicity. Science 2004;304:1269-1273. (Pubitemid 38697412)
5. Karas RH: Current controversies regarding the cardiovascular effects of hormone therapy. Clin Obstet Gynecol 2004;47:489-499. (Pubitemid 38879103)
6. Fulfaro F, Casuccio A, Ticozzi C, Ripamonti C: The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 1998;78:157-169. (Pubitemid 29052273)
7. Salari Sharif P, Abdollahi M, Larijani B: Current, new and future treatments of osteoporosis. Rheumatol Int 2010;31:289-300.
8. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B: Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004;3:379-389. (Pubitemid 40246708)
9. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME: Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992;102:341-351.
10. Beresford JN: Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res 1989;270-280. (Pubitemid 19072149)
11. Rosen CJ, Bouxsein ML: Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006;2:35-43. (Pubitemid 43153647)
12. Bianco P, Riminucci M, Gronthos S, Robey PG: Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001;19:180-192. (Pubitemid 32524539)
13. Park KW, Halperin DS, Tontonoz P: Before they were fat: adi-pocyte progenitors. Cell Metab 2008;8:454-457.
14. Tontonoz P, Spiegelman BM: Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008;77:289-312.
15. Hong JW, Park KW: Further understanding of fat biology: lessons from a fat fly. Exp Mol Med 2010;42:12-20.
16. Halade GV, Rahman MM, Williams PJ, Fernandes G: High fat diet-induced animal model of age-associated obesity and osteoporosis. J Nutr Biochem 2010;21:1162-1169.
17. Botolin S, McCabe LR: Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2007;148:198-205. (Pubitemid 46021451)
18. Putnam SE, Scutt AM, Bicknell K, Priestley CM, Williamson EM: Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res 2007;21:99-112.
19. Shim JG, Yeom SH, Kim HJ, et al.: Bone loss preventing effect of Sophorae Fructus on ovariectomized rats. Arch Pharm Res 2005;28:106-110.
20. Lee J, Kim KW, Kim HK, et al.: The effect of Rexflavone (Sophorae Fructus extract) on menopausal symptoms in post-menopausal women: a randomized double-blind placebo controlled clinical trial. Arch Pharm Res 2010;33:523-530.
21. Jung SR, Song NJ, Hwang HS, et al.: Silk peptides inhibit adipocyte differentiation through modulation of the Notch pathway in C3H10T1/2 cells. Nutr Res 2011;31:723-730.
22. Park KW, Waki H, Kim WK, et al.: The small molecule phe-namil induces osteoblast differentiation and mineralization. Mol Cell Biol 2009;29:3905-3914.
23. Jung SR, Kim YJ, Gwon AR, et al.: Genistein mediates the anti-adipogenic actions of Sophora japonica L. extracts. J Med Food 2011;14:360-368.
24. Soleimani S, Van Geel PJ, Isgor OB, Mostafa MB: Modeling of biological clogging in unsaturated porous media. J Contam Hy-drol 2009;106:39-50.
25. Lim SH, Ha TY, Kim SR, et al.: Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats. Br J Nutr 2009;101:1031-1039.
26. Palumbo C, Ferretti M, Bertoni L, et al.: Influence of ferutinin on bone metabolism in ovariectomized rats. I: role in preventing osteoporosis. J Bone Miner Metab 2009;27:538-545.
27. Aires A, Fernandes C, Carvalho R, et al.: Seasonal effects on bioactive compounds and antioxidant capacity of six economically important brassica vegetables. Molecules 2011;16: 6816-6832.
28. Folwarczna J, Zych M, Burczyk J, Trzeciak H, Trzeciak HI: Effects of natural phenolic acids on the skeletal system of ovariectomized rats. Planta Med 2009;75:1567-1572.
29. Hsu CL, Wu CH, Huang SL, Yen GC: Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats. J Agric Food Chem 2009;57:425-431.
30. Edgar JA, Lin HJ, Kumana CR, Ng MM: Pyrrolizidine alkaloid composition of three Chinese medicinal herbs, Eupatorium cannabinum, E. japonicum and Crotalaria assamica. Am J Chin Med 1992;20:281-288.
31. Hendriks H, Malingre TM, Elema ET: Pyrrolizidine alkaloids, flavonoids and volatile compounds in the genus Eupatorium. Eupatorium cannabinum L., an ancient drug with new perspectives. Pharm Weekbl Sci 1983;5:281-286. (Pubitemid 14176910)
32. Carey JJ: What is a ''failure'' of bisphosphonate therapy for osteoporosis? Cleve Clin J Med 2005;72:1033-1039.
33. Ott SM: What is the optimal duration of bisphosphonate therapy? Cleve Clin J Med 2011;78:619-630.